Leptin is a hormone that regulates food intake and energy metabolism. Its coding gene (LEP) is one of the most promising candidates for obesity. Although some studies have detected associations of different single nucleotide polymorphisms (SNPs) in the LEP gene with serum leptin levels and obesity-related traits, the results are still conflicting. We investigated two SNPs to find relationships with leptin concentrations. Thirty healthy Caucasian infants younger than 6 months were genotyped for the SNPs G2548A and A19G with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and amplification refractory mutation system-mismatch amplification mutation assay (ARMS- MAMA) real-time PCR, and serum leptin concentrations were measured with a radioimmunoassay method. Considering the significant linkage disequilibrium observed between the two SNPs, we divided the sample according to the number of GG haplotypes and observed that individuals homozygous for the GG haplotype had higher serum leptin levels in early infancy than the others. Although these preliminary results are based on a limited sample, they suggest that the genetic background seems to play a role in modulating leptin levels in infancy, but changes in leptin levels over infancy and their correlation with obesity need to be further explored. We describe an ARMS-MAMA real-time PCR procedure which could be profitably applied in routine genetic screening.

Keywords:
Infancy, Leptin gene polymorphisms, SNP G2548A, SNP A19G, PCR-RFLP, ARMS-MAMA real-time PCR analysis, Serum leptin concentrations
1.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
2.
Hassink SG, de Lancey E, Sheslow DV, Smith-Kirwin SM, O'Connor DM, Considine RV, et al: Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatrics 1997;100:E1.
3.
Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, et al: The stomach is a source of leptin. Nature 1998;394:790-793.
4.
Smith-Kirwin SM, O'Connor DM, De Johnston J, Lancey ED, Hassink SG, Funanage VL: Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 1998;83:1810-1813.
5.
Elmquist JK: Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int J Obes Relat Metab Disord 2001;25(suppl 5):S78-S82.
6.
Savino F, Liguori SA, Benetti S, Sorrenti M, Fissore MF, Cordero di Montezemolo L: High serum leptin levels in infancy can potentially predict obesity in childhood, especially in formula-fed infants. Acta Paediatr 2013;102:e455-e459.
7.
Gluckman PD, Hanson MA, Spencer HG: Predictive adaptive responses and human evolution. Trends Ecol Evol 2005;20:527-533.
8.
Bell CG, Walley AJ, Froguel P: The genetics of human obesity. Nat Rev Genet 2005;6:221-234.
9.
Isse N, Ogawa Y, Tamura N, Masuzaki H, Mori K, Okazaki T, et al: Structural organization and chromosomal assignment of the human obese gene. J Biol Chem 1995;270:27728-27733.
10.
Saeed S, Bonnefond A, Manzoor J, Shabir F, Ayesha H, Philippe J, et al: Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity 2015;23:1687-1695.
11.
Wabitsch M, Funcke JB, von Schnurbein J, Denzer F, Lahr G, Mazen I, et al: Severe early-onset obesity due to bioinactive leptin caused by a p.N103K mutation in the leptin gene. J Clin Endocrinol Metab 2015;100:3227-3230.
12.
Sahin DS, Tumer C, Demir C, Celik MM, Celik M, Ucar E, et al: Association with leptin gene C.-2548 G>A polymorphism, serum leptin levels, and body mass index in Turkish obese patients. Cell Biochem Biophys 2013;65:243-247.
13.
Fourati M, Mnif M, Kharrat N, Charfi N, Kammoun M, Fendri N, et al: Association between leptin gene polymorphisms and plasma leptin level in three consanguineous families with obesity. Gene 2013;527:75-81.
14.
Gong DW, Bi S, Pratley RE, Weintraub BD: Genomic structure and promoter analysis of the human obese gene. J Biol Chem 1996;271:3971-3974.
15.
Hart Sailors ML, Folsom AR, Ballantyne CM, Hoelscher DM, Jackson AS, Linda Kao WH, et al: Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities Study. Diabetes Obes Metab 2007;9:548-557.
16.
Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al: Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-2516.
17.
Glaab WE, Skopek TR: A novel assay for allelic discrimination that combines the fluorogenic 5′ nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay. Mutat Res 1999;430:1-12.
18.
Bergallo M, Gambarino S, Loiacono E, Vergano L, Galliano I, Montanari P, et al: Evaluation of IFN-γ polymorphism +874 T/A in patients with recurrent tonsillitis by PCR real time mismatch amplification mutation assay (MAMA real time PCR). Cytokine 2015;71:278-282.
19.
Raymond M, Rousset F: An exact test for population differentiation. Evolution 1995;49:1280-1283.
20.
Stephens M, Scheet P: Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 2005;76:449-462.
21.
Haschke F, van't Hof MA: Euro-Growth references for length, weight, and body circumferences. Euro-Growth Study Group. J Pediatr Gastroenterol Nutr 2000;31(suppl 1):S14-S38.
22.
Savino F, Rossi L, Benetti S, Petrucci E, Sorrenti M, Silvestro L: Serum reference values for leptin in healthy infants. PLoS One 2014;9:e113024.
23.
Savage SA, Reilly JJ, Edwards CA, Durnin JV: Adequacy of standards for assessment of growth and nutritional status in infancy and early childhood. Arch Dis Child 1999;80:121-124.
24.
Hassanzadeh T, Maleki M, Saidijam M, Paoli M: Association between leptin gene G-2548A polymorphism with metabolic syndrome. J Res Med Sci 2013;18:668-673.
25.
Lucantoni R, Ponti E, Berselli ME, Savia G, Minocci A, Calò G, et al: The A19G polymorphism in the 5′ untranslated region of the human obese gene does not affect leptin levels in severely obese patients. J Clin Endocrinol Metab 2000;85:3589-3591.
26.
Karvonen MK, Pesonen U, Heinonen P, Laakso M, Rissanen A, Naukkarinen H, et al: Identification of new sequence variants in the leptin gene. J Clin Endocrinol Metab 1998;83:3239-3242.
27.
Hager J, Clement K, Francke S, Dina C, Raison J, Lahlou N, et al: A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord 1998;22:200-205.
28.
Mammès O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F: Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 2000;64:391-394.
29.
Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P: A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002;34:355-359.
30.
Yiannakouris N, Melistas L, Yannakoulia M, Mungal K, Mantzoros CS: The -2548G/A polymorphism in the human leptin gene promoter region is associated with plasma free leptin levels; interaction with adiposity and gender in healthy subjects. Hormones (Athens) 2003;2:229-236.
31.
Shahid A, Rana S, Mahmood S, Saeed S: Role of leptin G-2548A polymorphism in age- and gender-specific development of obesity. J Biosci 2015;40:521-530.
32.
Okpechi IG, Rayner BL, van der Merwe L, Mayosi BM, Adeyemo A, Tiffin N, et al: Genetic variation at selected SNPs in the leptin gene and association of alleles with markers of kidney disease in a Xhosa population of South Africa. PLoS One 2010;5:e9086.
33.
Fan S-H, Say Y-H: Leptin and leptin receptor gene polymorphisms and their association with plasma leptin levels and obesity in a multi-ethnic Malaysian suburban population. J Physiol Anthropol 2014;33:15.
34.
Paracchini V, Pedotti P, Taioli E: Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 2005;162:101-114.
35.
Ghalandari H, Hosseini-Esfahani F, Mirmiran P: The association of polymorphisms in leptin/leptin receptor genes and ghrelin/ghrelin receptor genes with overweight/obesity and the related metabolic disturbances: a review. Int J Endocrinol Metab 2015;13:e19073.
36.
Angeli CB, Kimura L, Auricchio MT, Vicente JP, Mattevi VS, Zembrzuski VM, et al: Multilocus analyses of seven candidate genes suggest interacting pathways for obesity-related traits in Brazilian populations. Obesity (Silver Spring) 2011;19:1244-1251.
37.
Okada T, Ohzeki T, Nakagawa Y, Sugihara S, Arisaka O: Impact of leptin and leptin-receptor gene polymorphisms on serum lipids in Japanese obese children. Acta Paediatr 2010;99:1213-1217.
38.
Riestra P, García-Anguita A, Schoppen S, López-Simón L, De Oya M, Garcés C: Sex-specific association between leptin receptor polymorphisms and leptin levels and BMI in healthy adolescents. Acta Paediatr 2010;99:1527-1530.
39.
Fields DA, Demerath EW: Relationship of insulin, glucose, leptin, IL-6 and TNF-α in human breast milk with infant growth and body composition. Pediatr Obes 2012;7:304-312.
40.
Çatlı G, Olgaç Dündar N, Dündar BN: Adipokines in breast milk: an update. J Clin Res Pediatr Endocrinol 2014;6:192-201.
41.
Cheung WW, Mao P: Recent advances in obesity: genetics and beyond. ISRN Endocrinol 2012;2012:536905.
42.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
43.
Sáinz N, González-Navarro CJ, Martínez JA, Moreno-Aliaga MJ: Leptin signaling as a therapeutic target of obesity. Expert Opin Ther Targets 2015;1-17.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.